Cell Expansion Technologies Market (Updated Version Available)

Depending upon the type of cell, the global cell expansion market can be broadly split into human cells and animal cells. The human cell can be further divided into stem cells and differentiated cells. Revenue-wise, the human stem cell segment accounts for a dominant share in the market on account of the rising prevalence of various chronic diseases and support provided by the government. In 2016, it held a substantial 58.1% share in the overall revenue in the global cell expansion market.

Geographically, the key segments of the market are Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. Among them, North America is the leading market on account of the concentration of many key players in the region and the increasing research and development in the field. Going forward, North America is slated to slightly pare its market share to hold a 37.7% share in it by 2024. It will still, however, remain the dominant market.
In 2020, the market size of Cell Expansion Technologies is 10700 million US$ and it will reach 33700 million US$ in 2025, growing at a CAGR of 17.8% from 2020; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2019 has been considered as the base year and 2020 to 2025 as the forecast period to estimate the market size for Cell Expansion Technologies.

This report studies the global market size of Cell Expansion Technologies, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cell Expansion Technologies sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2020, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2020.

In global market, the following companies are covered:
Becton
Dickinson
GE Healthcare
Thermo Fisher Scientific Inc.
Corning Inc
Danaher Corp
Merck Millipore
Terumo BCT
STEMCELL Technologies
Sigma-Aldrich Corp
Miltenyi Biotec
Life Technologies
Replicell
Neximmune
TC Biopharm
Pluristem Therapeutics
ReNeuron
Voria Biomaterials
CellProthera
Cytomatrix

Market Segment by Product Type
Reagents
Media
Sera
Disposables

Market Segment by Application
Clinical diagnostics
Drug discovery and development
Regenerative medicine
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Cell Expansion Technologies status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cell Expansion Technologies manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Cell Expansion Technologies are as follows:
History Year: 2014-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2025